---
figid: PMC7493230__10.1177_1758835920953731-fig4
figtitle: Proposed mechanism for the EGFR/c-Met-mTOR/S6K signaling axis in NSCLC
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7493230
filename: 10.1177_1758835920953731-fig4.jpg
figlink: pmc/articles/PMC7493230/figure/fig4-1758835920953731/
number: F4
caption: A proposed mechanism for the EGFR/c-Met-mTOR/S6K signaling axis in NSCLC.
  Both EGFR and c-Met expression can lead to activation of the PI3K, mTOR, and MAPK
  pathways, resulting in increased cell proliferation, survival, migration, and angiogenesis
  through downstream targets such as Cyclin D1, p21, Bcl-2, wee-1, c-fos, c-jun and
  fosL1.– In addition, Wnt pathway activation leads to the recruitment of Axin2, CKI,
  and GSK-3, allowing for nuclear accumulation of active beta-catenin and enhanced
  transcription. Finally, it is shown that upregulation of Axin2, a negative regulator
  of the Wnt signaling pathway, can bind to GSK3 and lead to phosphorylation and degradation
  of beta-catenin. NSCLC, non-small cell lung cancer.
papertitle: EGFR/c-Met and mTOR signaling are predictors of survival in non-small
  cell lung cancer.
reftext: Zachary D Crees, et al. Ther Adv Med Oncol. 2020;12:1758835920953731.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9621795
figid_alias: PMC7493230__F4
figtype: Figure
redirect_from: /figures/PMC7493230__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7493230__10.1177_1758835920953731-fig4.html
  '@type': Dataset
  description: A proposed mechanism for the EGFR/c-Met-mTOR/S6K signaling axis in
    NSCLC. Both EGFR and c-Met expression can lead to activation of the PI3K, mTOR,
    and MAPK pathways, resulting in increased cell proliferation, survival, migration,
    and angiogenesis through downstream targets such as Cyclin D1, p21, Bcl-2, wee-1,
    c-fos, c-jun and fosL1.– In addition, Wnt pathway activation leads to the recruitment
    of Axin2, CKI, and GSK-3, allowing for nuclear accumulation of active beta-catenin
    and enhanced transcription. Finally, it is shown that upregulation of Axin2, a
    negative regulator of the Wnt signaling pathway, can bind to GSK3 and lead to
    phosphorylation and degradation of beta-catenin. NSCLC, non-small cell lung cancer.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - fz
  - im
  - CkIalpha
  - dsh
  - 'On'
  - sgg
  - Axn
  - ras
  - Ras64B
  - Ras85D
  - gig
  - Raf
  - Rheb
  - raptor
  - Crtc
  - 'Off'
  - arm
  - S6k
  - Erk7
  - rl
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4E1
  - eIF4EHP
  - Thor
  - RpS6
  - Debcl
  - dap
  - BC1
  - bc2
  - kay
  - Jra
  - Wee1
  - pan
  - HGF
  - IL6
  - SOS1
  - EGF
  - LRP5
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - CHKA
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - GSK3A
  - GSK3B
  - AXIN1
  - AXIN2
  - KRAS
  - HRAS
  - NRAS
  - TSC2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - RHEB
  - RHEBP1
  - MTOR
  - RPTOR
  - CTNNB1
  - RPS6KB1
  - RPS6KB2
  - EPHB2
  - MAPK1
  - MAPK3
  - EIF4E
  - EIF4E2
  - EIF4E3
  - EIF4EBP1
  - RPS6
  - BCL2
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CHMP2A
  - FOS
  - JUN
  - WEE1
  - FOSL1
  - HNF4A
  - EGFR
---
